These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7095696)

  • 21. [Basic diagnosis and conservative therapy in patients with calcium calculus diathesis].
    Horn HD
    Dtsch Med J; 1970 Apr; 21(8):506-12. PubMed ID: 5510196
    [No Abstract]   [Full Text] [Related]  

  • 22. [Studies of phosphate therapy of urinary calculi].
    Kollwitz AA; Kracht H; Meier F
    Urologe; 1966 Jul; 5(4):168-71. PubMed ID: 4296919
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
    Iguchi M; Ikegami M; Kiwamoto H; Umekawa T; Ishikawa Y; Kohri K; Kurita T
    Hinyokika Kiyo; 1993 May; 39(5):425-31. PubMed ID: 8322624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The simple and the extended diagnosis of urinary calculi].
    Toggenburg H; Bandhauer K
    Ther Umsch; 1980 May; 37(5):348-55. PubMed ID: 6248998
    [No Abstract]   [Full Text] [Related]  

  • 25. Estrogen replacement increased the citrate and calcium excretion rates in postmenopausal women with recurrent urolithiasis.
    Dey J; Creighton A; Lindberg JS; Fuselier HA; Kok DJ; Cole FE; Hamm L
    J Urol; 2002 Jan; 167(1):169-71. PubMed ID: 11743298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Teecura - tea for the prevention of urinary calculi recurrence].
    Bach D; Hesse A; Strenge A; Vahlensieck W
    ZFA (Stuttgart); 1981 May; 57(14):1113-8. PubMed ID: 7269761
    [No Abstract]   [Full Text] [Related]  

  • 27. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
    Sakhaee K; Poindexter JR; Griffith CS; Pak CY
    J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of citrates in a group of patients with idiopathic calcium calculi].
    Caudarella R; Malavolta N; Rizzoli E; Stefani F; D'Antuono G
    G Clin Med; 1985; 66(3-4):126-34. PubMed ID: 4029530
    [No Abstract]   [Full Text] [Related]  

  • 29. [What foods should stone formers avoid?].
    Amasaki N; Kurita T
    Hinyokika Kiyo; 2004 Aug; 50(8):573-5. PubMed ID: 15471079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary citrate, bone resorption and intestinal alkali absorption in stone formers with fasting hypercalciuria.
    Messa P; Mioni G; Paganin L; Cruciatti A; Greco PL; Turrin D
    Scanning Microsc; 1994; 8(3):531-8; discussion 538-9. PubMed ID: 7747155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Urinary oxalate excretion in the patients with upper urinary tract calculi].
    Ueda H
    Nihon Hinyokika Gakkai Zasshi; 1985 Mar; 76(3):338-47. PubMed ID: 4032899
    [No Abstract]   [Full Text] [Related]  

  • 32. [To what extent does a diet varying in calcium influence recurrent lithiasis in idiopathic hypercalciuria?].
    Peña JC
    Rev Invest Clin; 2002; 54(2):105-7. PubMed ID: 12053806
    [No Abstract]   [Full Text] [Related]  

  • 33. [Contribution to the problem of preventing recurrences of oxalate and phosphate urinary caluli: active modification of citrate excretion and Ca++-binding capacity in the urine of Wistar rats].
    Leskovar P; Hropot M; Wellnhofer E; Scherm D; Schade KL
    Z Urol Nephrol; 1982 Mar; 75(3):181-7. PubMed ID: 7102130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preventive treatment of oxalic lithiasis with an hypo-oxaluric: agent succinimide].
    Thomas J; Melon JM; Steg A; Aboulker P
    J Urol Nephrol (Paris); 1971 Dec; 77():Suppl:534-40. PubMed ID: 5155480
    [No Abstract]   [Full Text] [Related]  

  • 35. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Exaggerated calciuric response to an acute acid load in patients forming renal calcium stones].
    Normand M; Cayotte JL; Houillier P; Peuchant A; Paillard M
    Nephrologie; 1993; 14(6):283-5. PubMed ID: 8145886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Citric acid excretion in stone-formers and healthy controls on normal and standard diet (author's transl)].
    Bach D; Hesse A; Vahlensieck W
    Urologe A; 1980 Jul; 19(4):220-5. PubMed ID: 7414767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
    Laube N; Jansen B; Hesse A
    Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Attempts at regulation of urinary excretion of citrates].
    Hartung R; Leskovar P; Hropot M
    Helv Chir Acta; 1982 Aug; 49(3-4):435-9. PubMed ID: 7129915
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.